Louisiana's Novel 'Subscription' Model For Pricey Hepatitis C Drugs Gains Approval

By Selena Simmons-Duffin,
Alison Kodjak
Published June 26, 2019 at 4:28 PM CDT
  • Twitter
  • LinkedIn
  • Email
  • Twitter
  • LinkedIn
  • Email
Selena Simmons-Duffin
Selena Simmons-Duffin reports on health policy for NPR.
See stories by Selena Simmons-Duffin
Alison Kodjak
Alison Fitzgerald Kodjak is a health policy correspondent on NPR's Science Desk.
See stories by Alison Kodjak